677 related articles for article (PubMed ID: 26285644)
21. Loss of E-cadherin is not a necessity for epithelial to mesenchymal transition in human breast cancer.
Hollestelle A; Peeters JK; Smid M; Timmermans M; Verhoog LC; Westenend PJ; Heine AA; Chan A; Sieuwerts AM; Wiemer EA; Klijn JG; van der Spek PJ; Foekens JA; Schutte M; den Bakker MA; Martens JW
Breast Cancer Res Treat; 2013 Feb; 138(1):47-57. PubMed ID: 23338761
[TBL] [Abstract][Full Text] [Related]
22. Sef Regulates Epithelial-Mesenchymal Transition in Breast Cancer Cells.
He Q; Gong Y; Gower L; Yang X; Friesel RE
J Cell Biochem; 2016 Oct; 117(10):2346-56. PubMed ID: 26950413
[TBL] [Abstract][Full Text] [Related]
23. Isochlorogenic Acid C Reverses Epithelial-Mesenchymal Transition
Yu JK; Yue CH; Pan YR; Chiu YW; Liu JY; Lin KI; Lee CJ
Anticancer Res; 2018 Apr; 38(4):2127-2135. PubMed ID: 29599331
[TBL] [Abstract][Full Text] [Related]
24. Estrogen receptor beta as epigenetic mediator of miR-10b and miR-145 in mammary cancer.
Piperigkou Z; Franchi M; Götte M; Karamanos NK
Matrix Biol; 2017 Dec; 64():94-111. PubMed ID: 28797712
[TBL] [Abstract][Full Text] [Related]
25. Downregulation of transcription factor Oct4 induces an epithelial-to-mesenchymal transition via enhancement of Ca2+ influx in breast cancer cells.
Hu J; Qin K; Zhang Y; Gong J; Li N; Lv D; Xiang R; Tan X
Biochem Biophys Res Commun; 2011 Aug; 411(4):786-91. PubMed ID: 21798248
[TBL] [Abstract][Full Text] [Related]
26. Interleukin-6/STAT3 signalling regulates adipocyte induced epithelial-mesenchymal transition in breast cancer cells.
Gyamfi J; Lee YH; Eom M; Choi J
Sci Rep; 2018 Jun; 8(1):8859. PubMed ID: 29891854
[TBL] [Abstract][Full Text] [Related]
27. Sox5 induces epithelial to mesenchymal transition by transactivation of Twist1.
Pei XH; Lv XQ; Li HX
Biochem Biophys Res Commun; 2014 Mar; 446(1):322-7. PubMed ID: 24607904
[TBL] [Abstract][Full Text] [Related]
28. Genetic manipulation of stromal cell-derived factor-1 attests the pivotal role of the autocrine SDF-1-CXCR4 pathway in the aggressiveness of breast cancer cells.
Kang H; Mansel RE; Jiang WG
Int J Oncol; 2005 May; 26(5):1429-34. PubMed ID: 15809737
[TBL] [Abstract][Full Text] [Related]
29. Breast cancer-associated fibroblasts induce epithelial-to-mesenchymal transition in breast cancer cells.
Soon PS; Kim E; Pon CK; Gill AJ; Moore K; Spillane AJ; Benn DE; Baxter RC
Endocr Relat Cancer; 2013 Feb; 20(1):1-12. PubMed ID: 23111755
[TBL] [Abstract][Full Text] [Related]
30. Influence of stromal-epithelial interactions on breast cancer in vitro and in vivo.
Potter SM; Dwyer RM; Hartmann MC; Khan S; Boyle MP; Curran CE; Kerin MJ
Breast Cancer Res Treat; 2012 Jan; 131(2):401-11. PubMed ID: 21344235
[TBL] [Abstract][Full Text] [Related]
31. Isolation and characterization of CD105+/CD90+ subpopulation in breast cancer MDA-MB-231 cell line.
Wang X; Liu Y; Zhou K; Zhang G; Wang F; Ren J
Int J Clin Exp Pathol; 2015; 8(5):5105-12. PubMed ID: 26191205
[TBL] [Abstract][Full Text] [Related]
32. Macrophage phenotypic subtypes diametrically regulate epithelial-mesenchymal plasticity in breast cancer cells.
Yang M; Ma B; Shao H; Clark AM; Wells A
BMC Cancer; 2016 Jul; 16():419. PubMed ID: 27387344
[TBL] [Abstract][Full Text] [Related]
33. P2Y2 nucleotide receptor-mediated extracellular signal-regulated kinases and protein kinase C activation induces the invasion of highly metastatic breast cancer cells.
Eun SY; Ko YS; Park SW; Chang KC; Kim HJ
Oncol Rep; 2015 Jul; 34(1):195-202. PubMed ID: 26063340
[TBL] [Abstract][Full Text] [Related]
34. Staged stromal extracellular 3D matrices differentially regulate breast cancer cell responses through PI3K and beta1-integrins.
Castelló-Cros R; Khan DR; Simons J; Valianou M; Cukierman E
BMC Cancer; 2009 Mar; 9():94. PubMed ID: 19323811
[TBL] [Abstract][Full Text] [Related]
35. Niclosamide reverses adipocyte induced epithelial-mesenchymal transition in breast cancer cells via suppression of the interleukin-6/STAT3 signalling axis.
Gyamfi J; Lee YH; Min BS; Choi J
Sci Rep; 2019 Aug; 9(1):11336. PubMed ID: 31383893
[TBL] [Abstract][Full Text] [Related]
36. Interaction Between Ezrin and Cortactin in Promoting Epithelial to Mesenchymal Transition in Breast Cancer Cells.
He J; Ma G; Qian J; Zhu Y; Liang M; Yao N; Ding Q; Chen L; Liu X; Xia T; Wang S
Med Sci Monit; 2017 Apr; 23():1583-1596. PubMed ID: 28364518
[TBL] [Abstract][Full Text] [Related]
37. Invasion and increased expression of S100A4 and CYR61 in mesenchymal transformed breast cancer cells is downregulated by GnRH.
Gründker C; Bauerschmitz G; Schubert A; Emons G
Int J Oncol; 2016 Jun; 48(6):2713-21. PubMed ID: 27098123
[TBL] [Abstract][Full Text] [Related]
38. TGF-β1 induces HMGA1 expression in human breast cancer cells: implications of the involvement of HMGA1 in TGF-β signaling.
Zu X; Zhong J; Tan J; Tan L; Yang D; Zhang Q; Ding W; Liu W; Wen G; Liu J; Cao R; Jiang Y
Int J Mol Med; 2015 Mar; 35(3):693-701. PubMed ID: 25572132
[TBL] [Abstract][Full Text] [Related]
39. Extracellular Matrix Derived from High Metastatic Human Breast Cancer Triggers Epithelial-Mesenchymal Transition in Epithelial Breast Cancer Cells through αvβ3 Integrin.
M Brandão-Costa R; Helal-Neto E; M Vieira A; Barcellos-de-Souza P; Morgado-Diaz J; Barja-Fidalgo C
Int J Mol Sci; 2020 Apr; 21(8):. PubMed ID: 32340328
[TBL] [Abstract][Full Text] [Related]
40. Acquisition of epithelial-mesenchymal transition phenotype in the tamoxifen-resistant breast cancer cell: a new role for G protein-coupled estrogen receptor in mediating tamoxifen resistance through cancer-associated fibroblast-derived fibronectin and β1-integrin signaling pathway in tumor cells.
Yuan J; Liu M; Yang L; Tu G; Zhu Q; Chen M; Cheng H; Luo H; Fu W; Li Z; Yang G
Breast Cancer Res; 2015 May; 17(1):69. PubMed ID: 25990368
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
